Associate Director, Data and Knowledge Management
Boost your chances before you apply.
Vaxcyte
San Carlos, CA, US
Summary
Lead enterprise-wide efforts to structure, govern, and utilize data and knowledge assets to support process development, clinical, and regulatory activities. Establish systems to capture institutional knowledge and ensure data integrity for commercial regulatory submissions.
Job Description
Join our Mission to Protect Humankind!
Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance.
WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values:
*RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered.
*AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind.
*LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives.
*MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making.
Summary:
As we grow, we are seeking a strategic and collaborative Associate Director of Data and Knowledge Management to ensure the integrity, accessibility, and effective use of data and knowledge assets across the organization.
The Associate Director of Data and Knowledge Management will lead enterprise-wide efforts to structure, govern, and utilize data and knowledge resources critical to our process development, clinical, regulatory, and operational activities. This role is instrumental in ensuring scientific data integrity, regulatory readiness, and the preservation of institutional knowledge in a dynamic, fast-paced clinical environment.
Essential Functions:
Data Management, Strategy & Governance:
- Acquire and gather data from manufacturing nodes throughout the supply chain to enable regulatory filings, process monitoring, and continuous improvement.
- Develop and oversee data management strategies to support operations, development, and regulatory submissions.
- Own data verification for all commercial regulatory submissions.
- Lead the integration of structured and unstructured data across departments (e.g., preclinical, clinical, regulatory, CMC).
Knowledge Management:
- Build systems and workflows to capture and retain organizational knowledge, including protocols, study results, lessons learned, and decision rationales.
- Develop tools and processes that enable scientific teams to find, share, and reuse knowledge efficiently.
- Champion a knowledge-sharing culture across scientific and operational functions.
Collaboration & Leadership:
- Partner with regulatory, quality, R&D, IT and contract manufacturing teams to understand data and knowledge needs and align solutions.
- Lead cross-functional initiatives focused on digital transformation, data harmonization, and collaboration tools.
- Manage and mentor a team of data professionals, analysts, and knowledge specialists.
Analytics & Insights:
- Ensure timely access to high-quality data for operational decision-making.
- Partner with data science team to drive data visualization, reporting, and insights.
- Support the use of AI/ML and automation for improved data analysis and knowledge extraction.
Compliance & Risk Management:
- Ensure compliance with data protection and clinical trial regulations, including GDPR, HIPAA, and 21 CFR Part 11.
- Identify and mitigate risks related to data security, access, and retention
Requirements:
- Bachelor’s, Master’s or PhD degree in Life Sciences, Data Science, Information Management, or related field. Minimum of 9+ years of relevant experience for Ph.D., 11+ years for M.S./M.A., or 14+ years for B.S./B.A.
- 8+ years of experience in data and/or knowledge management, with minimum 3 years in a life sciences or biotech setting.
- Proven experience leading enterprise data governance and knowledge sharing initiatives in a highly regulated environment.
- Strong project management and communication skills; able to work cross-functionally with scientific and operational teams.
- Experience with tools like SharePoint, Veeva Vault, Confluence, Tableau, and SQL is highly desirable.
- Experience supporting clinical trials and regulatory submissions (e.g., IND, BLA) strongly preferred.
- Background in immunology, vaccines, or infectious disease R&D is highly preferred.
- Experience in scaling systems and processes in a high-growth, early- to mid-stage biotech company is preferred.
Reports to: Senior Director, Process Validation
Location: Cary, North Carolina, San Carlos, California or Philadelphia, Pennsylvania
Work Arrangement (may be adjusted based on business needs, job responsibilities, or changes to company policy):
Hybrid (Cary, North Carolina or San Carlos, California or Philadelphia, Pennsylvania) (minimum of 3 days per week onsite)
Compensation:
The compensation package will be competitive and includes comprehensive benefits and an equity component.
Salary Range: $183,000 – $214,000 (SF Bay Area). Salary ranges for non-California locations may vary.
Equal Opportunity
We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status.
Recruitment Fraud Notice
Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent Vaxcyte in recruitment activities. Vaxcyte has an established recruitment process for all positions prior to issuing an offer for employment and we will never extend unsolicited employment offers or ask candidates to provide financial or sensitive personal information as part of the application process. All legitimate communication from Vaxcyte will come from an official @vaxcyte.com email address. Qualified and interested candidates should apply to current openings at vaxcyte.com/careers.
Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases.
VAX-31, a 31-valent pneumococcal conjugate vaccine (PCV) candidate being evaluated in the OPUS Phase 3 adult clinical program and in a Phase 2 infant clinical program, is being developed for the prevention of invasive pneumococcal disease (IPD) and is the broadest-spectrum PCV candidate in the clinic today. VAX-24, a 24-valent PCV candidate, is designed to cover more serotypes than any infant PCV on-market. VAX-31 and VAX-24 are designed to improve upon standard-of-care PCVs by covering the serotypes in circulation that cause a significant portion of IPD and are associated with high case-fatality rates, antibiotic resistance and meningitis, while maintaining coverage of previously circulating strains. VAX-XL, in earlier-stage development, also leverages the Company’s carrier-sparing, site-specific conjugation technology with the aim of further expanding coverage to deliver the broadest-spectrum candidate in the Company’s PCV franchise.
Vaxcyte is re-engineering the way highly complex vaccines are made through XpressCF®, its cell-free protein synthesis platform exclusively licensed from Sutro Biopharma, Inc. Unlike conventional cell-based approaches, the Company’s system for producing difficult-to-make proteins and antigens is intended to accelerate its ability to develop high-fidelity vaccines with enhanced immunological benefits.
Vaxcyte’s pipeline also includes VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections, and VAX-GI, a vaccine candidate designed to prevent Shigella.
Founded
2013
Company size
501-1,000 employees
Industry
Biotechnology Research
Org type
Public Company
Headquarters
San Carlos, California
Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases.
VAX-31, a 31-valent pneumococcal conjugate vaccine (PCV) candidate being evaluated in the OPUS Phase 3 adult clinical program and in a Phase 2 infant clinical program, is being developed for the prevention of invasive pneumococcal disease (IPD) and is the broadest-spectrum PCV candidate in the clinic today. VAX-24, a 24-valent PCV candidate, is designed to cover more serotypes than any infant PCV on-market. VAX-31 and VAX-24 are designed to improve upon standard-of-care PCVs by covering the serotypes in circulation that cause a significant portion of IPD and are associated with high case-fatality rates, antibiotic resistance and meningitis, while maintaining coverage of previously circulating strains. VAX-XL, in earlier-stage development, also leverages the Company’s carrier-sparing, site-specific conjugation technology with the aim of further expanding coverage to deliver the broadest-spectrum candidate in the Company’s PCV franchise.
Vaxcyte is re-engineering the way highly complex vaccines are made through XpressCF®, its cell-free protein synthesis platform exclusively licensed from Sutro Biopharma, Inc. Unlike conventional cell-based approaches, the Company’s system for producing difficult-to-make proteins and antigens is intended to accelerate its ability to develop high-fidelity vaccines with enhanced immunological benefits.
Vaxcyte’s pipeline also includes VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections, and VAX-GI, a vaccine candidate designed to prevent Shigella.
Founded
2013
Company size
501-1,000 employees
Industry
Biotechnology Research
Org type
Public Company
Headquarters
San Carlos, California